PHOTO
- DHI 2048 established as a collaborative platform to drive collaboration among healthcare stakeholders in UAE and Israel
- Over Two billion dollars to be deployed in the next four years on healthcare equipment, training and AI based technologies
Dubai, UAE: HH Sheikh Tahnoon Bin Saeed Bin Shakhbout al Nahyan, chairman of Federal Group and Smart Vision for information technology signed cooperation agreement with Digital health innovation 2048 (DHI 2048) to streamline the adoption of best-in-class digital health products and innovative solutions from Israel.
DHI 2048 organisation launched in UAE is the part of latest cooperation to strengthen the ties between the UAE and Israel, following the Abraham Accords signed last year on August 13, 2020. The official high-profile launch of DHI 2048, which was supported by Department of Tourism & Commerce Marketing (DTCM) was attended by ambassadors from UAE and Israel, officials from health ministries and authorities, and leaders in public and private healthcare administration.
HH Sheikh Tahnoon Bin Saeed Bin Shakhbout al Nahyan, Chairman of Federal Group and Smart Vision for information technology, said, “We are truly thrilled to announce the new cooperation between Smart Vision for Information Systems and Digital Health Innovation “DHI2048” which aims to digitize the delivery of healthcare services in the UAE. This cooperation shall open the doors for a newly digitized era of delivering healthcare-related services using Artificial Intelligence and Robotics in the region and shall in return reduce the time and effort spent to produce accurate results and further improve the quality of healthcare services.”
Speaking at the launch event, Adiv Baruch - Chairman DHI 2048, talked about how advancement in digital solutions in healthcare will benefit everyone. The COVID-19 pandemic has accelerated many digital processes, leading to a growing need for cost-effective and efficient ways of healthcare delivery. He said, "the timely partnership between UAE and Israel will go way beyond and takes a hands-on approach to healthcare delivery across the MENA region. Deployment of Nanox systems, trainings and state-of-the-art AI technologies is just a start, and we aim to further accelerate the growth of health care sector with the support of our regional stakeholders”
The UAE-Israel collaboration will add huge value to the health sector, including both public and private hospitals. With the launch of DHI 2048, it is estimated that over two billion dollars will be deployed in the next four years. Joining hands with its Israeli partners; Nanox and Illumigyn, the collaborative platform aims to install 2100 Nanox systems in public and private hospitals, train the workforce including nurses, and deploy artificial technology to create a robust healthcare ecosystem. The introduction of this novel based technology is intended to promote the great mission of providing a worldwide end-to-end medical imaging solution that enables people to have early medical detection and better health
The healthcare ecosystem is witnessing a paradigm shift towards providing accessibility, helping affordability, and offering quality services to customers. UAE's health expenditure reached a value of USD15.0bn in 2020 and is expected to hit USD16.0bn in 2021, a 6.6% y-o-y increase. Further, it is estimated that spending will reach USD20.2b) by 2025, which translates to compound annual growth rate of 7.2%. *
-Ends-
* Understanding the UAE's Regional Healthcare Markets, 2021, Fitch solutions
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
